09-30 Fuso Pharmaceutical Industries, Ltd. Concludes Design-Build Contract with Chiyoda X-One Engineering Corporation for Okayama Second Factory CI
09-20 Fuso Pharmaceutical Industries,Ltd.(TSE:4538) added to S&P Global BMI Index CI
08-10 Fuso Pharmaceutical Industries,Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-18 Fuso Pharmaceutical Industries,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-12 Fuso Pharmaceutical Industries,Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2026, and Full Fiscal Year Ending March 31, 2027 CI
05-12 Fuso Pharmaceutical Industries,Ltd. Provides Dividend Guidance for the Second Quarter-End Fiscal Year Ending March 31, 2027 and Full Year Ending March 31, 2027 CI
05-12 Fuso Pharmaceutical Industries,Ltd. Proposes Year-End Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 25, 2026 CI
05-12 Fuso Pharmaceutical Industries,Ltd. Announces Board Changes, Effective June 24, 2026 CI
03-31 Fuso Pharmaceutical Industries, Ltd. Concludes Syndicated Loan Agreement CI
02-16 Fuso Pharmaceutical Industries' Nine-Month Profit Falls 30%; Sales Rise 3% MT
02-12 Fuso Pharmaceutical Industries,Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
11-10 Fuso Pharmaceutical Industries,Ltd. Announces Second Quarter-End Dividend for the Six Months Ended September 30, 2025, Payable on December 2, 2025 CI
25-08-01 Fuso Pharmaceutical Industries, Ltd. Announces Executive Officer Personnel Appointments, Effective September 1, 2025 CI
1 day+0.05%
1 week+0.14%
Current month+0.05%
1 month-2.63%
3 months-3.08%
6 months-5.51%
Current year-8.94%
1 week 2,067
Extreme 2067
2,122
1 month 2,067
Extreme 2067
2,183
Current year 1,990
Extreme 1990
2,530
1 year 1,990
Extreme 1990
2,530
3 years 1,841
Extreme 1841
2,858
5 years 1,841
Extreme 1841
2,858
10 years 1,320
Extreme 1320
3,090
Manager TitleAgeSince
President 83 1979-01-31
Chief Tech/Sci/R&D Officer 76 2011-03-31
Corporate Officer/Principal 51 2018-03-31
Director TitleAgeSince
Director/Board Member 83 1969-04-30
Director/Board Member 76 2013-05-31
Director/Board Member 61 2017-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%+0.14%-0.47%+8.55% 114M
-0.46%+10.31%+63.52%+143.15% 1,257B
-0.97%+1.60%+43.25%+80.09% 651B
-2.05%+0.73%+32.47%+101.62% 510B
-0.29%-0.83%+52.49%+66.79% 388B
-0.78%+5.51%+72.55%+44.25% 366B
+0.68%+2.97%+33.27%+59.11% 303B
+0.43%+8.64%+12.67%+35.64% 288B
-0.12%+4.68%+55.97%+74.59% 252B
-0.21%+7.34%+42.19%+109.69% 211B
Average -0.31%+4.15%+40.79%+72.35% 422.68B
Weighted average by Cap. -0.37%+5.30%+49.26%+93.73%
Logo Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries Ltd is a Japan-based company principally engaged in the manufacture and sale of pharmaceuticals and medical equipment. The pharmaceuticals business involves the manufacture and sale of pharmaceuticals and medical equipment, including injectables centered on infusion solutions and dialysis agents for artificial kidneys, as well as contract manufacturing of pharmaceuticals. The real estate business involves the leasing of real estate.
Employees
1,370
Date Price Change Volume
26-11-02 JP¥2,108.00 +0.05% 19,400
26-10-30 JP¥2,107.00 -0.14% 26,000
26-10-29 JP¥2,110.00 +1.20% 107,900
26-10-28 JP¥2,085.00 -0.67% 27,400
26-10-27 JP¥2,099.00 -0.29% 24,400
  1. Stock Market
  2. Stocks
  3. 4538 Stock